Main container

Health-related quality of life measurement strategy for solid rare cancers - Strategia per la misurazione della qualità di vita correlata alla salute nei tumori solidi rari

Title
Health-related quality of life measurement strategy for solid rare cancers - Strategia per la misurazione della qualità di vita correlata alla salute nei tumori solidi rari
Code
QUALITY-SARC
Type
Osservazionale
Start Year
2023
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
05/09/2023 11:18